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Micro-MRI methods to detect renal cysts in mice.
Background. Mouse models of disease, especially using trans-
genic and knockout technologies, are powerful tools to ana-
lyze the molecular basis of disease. We recently reported that
a new dynamic micro-MRI method with dendrimer-based con-
trast agents can visualize renal structure and function in normal
living mice and mice with acute renal failure. While MRI con-
trast enhancement is useful for detecting functional impairment
of the kidneys, this technology has limitations in assessing mor-
phologic changes, particularly cystic disease, because contrast-
enhanced micro-MRI depicts cysts as low-intensity areas that
cannot be distinguished from fibrotic foci.
Methods. In the current study, we evaluated if micro-MRI
employing a new three-dimensional MR hydrography signal se-
quence [three-dimensional fast imaging employing steady-state
acquisition (3D-FIESTA)] can visualize chronic cystic changes
without any contrast agents.
Results. We were able to positively depict multiple renal cor-
tical cysts of ∼0.2 mm diameter in a mouse model of sickle cell
disease and observe serial changes of renal cysts (>0.2 mm di-
ameter) in cyclooxygenase-2 (COX-2) knockout mice during a
21/2-month period. Some cysts decreased in size over time.
Conclusions. Micro-MRI with 3D-FIESTA can depict cyst
formation in the diseased kidneys of living mice without injec-
tion of contrast agents.
The major goal of renal imaging is to detect struc-
tural and functional abnormalities in vivo. The intrinsic
contrast of the kidney parenchyma is low on MRI. We
have recently shown that generation-4 (G4) dendrimer-
based contrast agents are concentrated in renal tubules,
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enabling visualization of renal structural and functional
injury in the mouse [1].
Chronic kidney disease is typically diagnosed by a com-
bination of chronic interstitial inflammation/fibrosis and
tubular atrophy, and is associated with cyst formation
[2, 3]. While serum creatinine is a useful biomarker of
chronic kidney disease in humans, serum creatinine is of-
ten not elevated in mouse models of renal disease [4].
Therefore, noninvasive detection of the changes in renal
anatomy or function can play an important role in doc-
umenting chronic kidney disease in animal models. We
employed a 1.5 Tesla clinical MRI system fitted with a
mouse coil and used a new three-dimensional fast imag-
ing employing steady-state acquisition (3D-FIESTA) to
visualize renal cysts in two mouse models of chronic renal
disease: sickle cell disease mice [3] and cyclooxygenase-2
(COX-2) knockout mice [2]. The 3D-FIESTA is a rela-
tively new water-sensitive fast sequence (MR hydrogra-
phy) that detects small amounts of fluid based on its long
T2 relaxation [5–7]. This three-dimensional steady-state
coherent imaging pulse sequence,3D-FIESTA, has re-
cently become available on clinical MRI machines (Signa
LX, GE, Milwaukee, WI, USA) and permits the acquisi-
tion of images with a 0.6 mm slice thickness while retain-
ing high signal-to-noise ratios at very short scan times.
In the present study, we performed MRI-pathologic
correlation studies on mice with chronic kidney diseases
to evaluate the sensitivity of non-contrast enhanced 3D-
FIESTA to detect cysts in mice with renal disease.
METHODS
Mouse models of experimental chronic kidney damage
The MRI methods were optimized in 2-month-old nor-
mal Balb/c mice (NCI, Frederick, MD, USA). For the
models of chronic kidney disease with cysts, we used
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8-month-old hemizygous sickle cell mice containing one
normal mouse beta-globin allele (N = 7), and 5- and
10-month-old COX-2 knockout mice (N = 4, in each
group). All studies were approved by the Animal Care
Committee of National Institutes of Health.
Three-dimensional micro-MRI of the kidney
The 3D-FIESTA sequence was performed with 45◦
flip angle (TR/TE 27.7/13.8 msec; scan time 2 minutes
29 seconds; frequency encoding × phase encoding steps
320 × 224; 3 numbers of excitation; 16 slice encod-
ing steps). The coronal images for MRI were recon-
structed from 0.6 mm thick sections without gap. The
field of view was 6 × 3 cm and the size of the matrix
was 0.19 × 0.27 mm. In addition, we examined most
of kidneys with two conventional MR hydrography se-
quences [2D-HASTE (two-dimensional half-Fourier ac-
quisition single-shot turbo spin-echo); ssfse-IR TR/TE
12939/38.7 msec; TI 150 msec; scan time 13 seconds; fre-
quency encoding × phase encoding steps 256 × 256; 1
number of excitation; field of view 8 × 8 cm] and 2D-
STIR [(two-dimensional short tau inversion recovery);
TR/TE 8000/102 msec; TI 150 msec; scan time 3 minutes
20 seconds; frequency encoding x phase encoding steps
512 × 256; 3 numbers of excitation; field of view 8 ×
4 cm)]. 2D-HASTE method was not able to detect the
kidney; whereas the 2D-STIR method could only depict
subcortical cysts as vague white lines for the same kidney
shown in Figure 2a (Fig. 2c and d). However, 3D-FIESTA
could detect small renal cysts. We tested 3D-FIESTA and
compared to contrast-enhanced three-dimensional fast-
spoiled gradient echo (SPGR) (T1-weighted) with the
G4-(1B4M-Gd)64 dendrimer agent (0.03 mmol/kg) as
previously described [1].
All scans were performed using a clinical grade 1.5
Tesla superconductive magnet unit (Signa LX) fitted with
an in-house constructed 1-inch bird cage–type coil [1].
The mice were anesthetized with subcutaneous injection
of 100 mg/kg of ketamine HCl (Fort Dodge, IA, USA)
and placed in the center of the coils. Mice underwent
T2-weighted noncontrast 3D-FIESTA imaging and then
were intravenously injected with G4 dendrimer agent fol-
lowing the imaging by contrast-enhanced T1-weighted
three-dimensional fast-SPGR.
RESULTS
Image quality of 3D-FIESTA in normal mice
We first compared the visualization of normal kidneys
using 3D-FIESTA (Fig. 1a) with G4 dendrimer contrast-
enhanced dynamic three-dimensional fast SPGR imaging
in 18 consecutive mice (N = 36 kidneys). The G4 den-
drimer agent is known to produce excellent imaging of
the kidney [1]. All of the dynamic MRIs obtained with G4
agent had a uniform appearance, as seen previously, with
Fig. 1. The MR kidney images in a normal mouse with three-
dimensional fast imaging employing steady-state acquisition (3D-
FIESTA) (a) and T1-weighted G4 dynamic (b) 9 minutes postinjection
are shown. The bars indicate the thickness of the cortex and outer stripe.
alternating bands of contrast in the cortex, outer stripe,
and inner medulla [1]. In contrast, we found that the 3D-
FIESTA method was susceptible to artifacts caused by
air in the adjacent intestine; the kidney parenchyma was
not visualized partially (N = 5) or totally (N = 1) in six of
36 normal kidneys. In order to simplify the experimental
protocol, we did not repeat scans to obtain better images
for this validation study (see Discussion section). In the
remaining 30 kidneys, the parenchyma of the kidney was
generally dark with a single thin faint bright band at the
outer stripe of the outer medulla. The water (urine) in
the pelvis was clearly depicted by 3D-FIESTA in all 30
kidneys as a bright area (see Fig. 1a).
3D-FIESTA can detect small renal cysts
We next evaluated the ability of these two methods
to detect renal cysts in hemizygous sickle cell mice. The
presence of these cysts was later confirmed by histologic
analysis (Fig. 3).
The 3D-FIESTA images of sickle cell mice clearly
showed bright cysts with diameters of ∼0.2 mm, even
when they were located near the renal capsule (Figs. 2
and 3). In contrast, whereas the dynamic MRI with G4
could detect internal cysts (dark circles), cysts near the
surface of the kidney indistinctly appeared as a wavy sur-
face contour, or were not detected (Figs. 2 and 3). Images
taken 3 days apart showed good reproducibility (Fig. 4)
(mean differences in size ± SD = 0.05 ± 0.02 mm; N =
19; r2 = 0.63) of cyst diameter.
We also evaluated both MRI methods in COX-2
knockout mice. The 3D-FIESTA method could detect
bright cysts in the inner stripe with a diameter of
∼0.2 mm (Figs. 5 and 6). Although cysts were visible on
G4 dynamic MRI, they were more easily identified on
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Fig. 2. The MR kidney images in a 8-month-old hemizygous sickle cell
mouse with chronic kidney damage using three-dimensional fast imag-
ing employing steady-state acquisition (3D-FIESTA) (a), T1-weighted
G4 dynamic (b) 9 minutes postinjection, and two conventional MR-
hydrography sequences [two-dimensional short tau inversion recovery
(2D-STIR) (c) and two-dimensional half-Fourier acquisition single-shot
turbo spin-echo (2D-HASTE) (d)] are shown. The arrows indicate mul-
tiple small cysts with diameter of ∼0.2 to 0.3 mm.
100 µm 100 µm
Subcapsular cysts
Subcortical cystsx20 x50
Fig. 3. Typical renal histology in a hemizygous sickle cell mouse. Ar-
rows show subcapsular cysts; asterisks show subcortical cysts.
3D-FIESTA (Figs. 5 and 6). Serial MRI examinations at
5 and 7.5 months in one mouse showed that two cysts
decreased their size from 5 to 71/2 months (Fig. 6). Serial
MRI examinations in four mice showed that some cysts
were stable, whereas others either increased or decreased
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Fig. 4. Diameters of cysts in eight cyclooxygenase-2 (COX-2) knock-
out mice measured on two separate MRI scans with three-dimensional
fast imaging employing steady-state acquisition (3D-FIESTA) method
taken 3 days apart are plotted. Data show good reproducibility (mean
differences in size ± SD = 0.05 ± 0.02 mm; N = 19; r2 = 0.63).
Fig. 5. The MR kidney images in a 10-month-old cyclooxygenase-2
(COX-2) knockout mouse with chronic kidney damage using three-
dimensional fast imaging employing steady-state acquisition (3D-
FIESTA) (a) and T1-weighted G4 dynamic (b) 9 minutes postinjection
are shown. The arrow indicates a cyst with diameter of ∼0.4 mm. The
bars indicate the thickness of the cortex and outer stripe.
in size. This decrease in size of four cysts was also found in
the other COX-2 knockout mice (Fig. 7). Since the three-
dimensional image acquisition covered the entire kidney
parenchyma without gap, we would not miss a cyst of
>0.3 mm as shown in Figure 6, although we could miss
cysts of smaller than 0.1 mm diameter.
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Fig. 6. The MR kidney images in a 5-month-old cyclooxygenase-2
(COX-2) knockout mouse with chronic kidney damage using three-
dimensional fast imaging employing steady-state acquisition (3D-
FIESTA) (a) and T1-weighted G4 dynamic (b) 9 minutes postinjection
are shown. The arrow indicates a small cyst with a diameter of ∼0.6 mm.
The MR kidney images in the same COX-2 knockout mouse obtained
21/2 months later using 3D-FIESTA (c) and T1-weighted G4 dynamic
(d) 9 minutes postinjection are shown. The cyst became almost nonvi-
sualized on the images (a white broken arrow). The black broken arrow
indicates nonenhancement area on the G4 image, which was not visual-
ized by 3D-FIESTA. The bars indicate the thickness of the cortex and
outer stripe.
DISCUSSION
The 3D-FIESTA is a relatively new sequence for MR
hydrography that has recently become available on clin-
ical MRI units and that is highly sensitive for fluid-
containing structures [8]. As demonstrated here, it can
dramatically improve the conspicuity of renal cysts. Re-
sults using the FIESTA sequence have recently been
reported in cardiac MRI and MR microscopy of cells
[5, 6, 9]. To the best of our knowledge, this is the first
reported use of 3D-FIESTA to analyze mouse models
of kidney disease. As previously shown [10, 11], three-
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Fig. 7. The changes of cyst sizes in the kidneys in cyclooxygenase-2
(COX-2) knockout mice depicted by the serial three-dimensional fast
imaging employing steady-state acquisition (3D-FIESTA) MR imaging
during 21/2 months are plotted.
dimensional data acquisition has permitted generation
of high-resolution micro-MR images in small animals.
The inherent higher signal-to-noise ratio allows thinner
0.6 mm slices to be obtained as compared with the
1.5 mm slice typically of conventional two-dimensional
data acquisition on a 1.5 Tesla unit. In addition, by using
overlapping reconstruction, we can avoid a 0.2 mm gap
between slices typical of two-dimensional data acquisi-
tion. Since the 3D-FIESTA method is very sensitive to the
local water environment, 3D-FIESTA images were able
to detect submillimeter renal cysts in mice with chronic
kidney damage, even when the cysts were located on the
surface of the cortex (Figs. 2 and 3). In addition, although
all kidney MRI images were obtained twice within a
3-day interval, 3D-FIESTA rarely missed cysts with di-
ameter more than 200 nm due to partial volume effects
or slice gaps. Unfortunately, 3D-FIESTA images tended
to be subject to susceptibility artifacts resultant from air
or metal in the vicinity of the kidney. However, since
colonic gas moves over time, one can potentially repeat
the scan after a short time interval to obtain a better image
(data not shown). Although we did not detect any hem-
orrhagic cysts by histology in this study, cyst hemorrhage
might compromise the signal intensity of the water con-
tained in the cyst because of susceptibility derived from
iron ions incorporated in the hemoglobin.
3D-FIESTA has several advantages over contrast-
enhanced imaging. First, 3D-FIESTA depicts cysts as
bright areas against a dark background, which are more
easily detected than dark areas against a bright back-
ground as visualized in contrast-enhanced imaging. Sec-
ond, a bright circle on a FIESTA scan is more specific for
Kobayashi et al: Micro-MRI of renal cysts in mice 1515
a cyst. For example, fibrosis or calcified lesions may also
show up as low intensity areas on contrast-enhanced T1-
weighted contrast images. Therefore, G4-enhanced MRI
showed many spotty low intensity areas, but only some
of them were cysts by 3D-FIESTA. In contrast, since 3D-
FIESTA only visualizes water-rich areas with high sig-
nal intensity, high signal areas indicate the presence of
cysts or urine (inner medulla). In addition, 3D-FIESTA
method depicted cysts better than conventional MR hy-
drography methods such as 2D-HASTE and 2D-STIR.
Third, and perhaps most important, 3D-FIESTA imag-
ing does not require injection of an intravenous contrast
agent.
Sun et al [12] have recently reported an MRI study of
the polycystic kidney model mouse with an 8.5 Tesla ani-
mal MRI system. In their study, the affected kidneys were
studied using a two-dimensional proton-weighted MRI.
The proton-weighted MRI did not specifically detect in-
dividual cysts, although it did show segmentation of cysts
and enlargement of the kidney. Because 3D-FIESTA has
a high signal-to-noise ratio, we only needed a clinical
1.5 Tesla MRI scanner to obtain 0.6 mm slices, whereas
Sun et al [12] used a research-grade 8.5 Tesla MRI ma-
chine to obtain 1.0 mm slides. Furthermore, since high
signal on 3D-FIESTA is specific for fluid-containing
structures, 3D-FIESTA might be useful for evaluating
the serial volume fraction changes, and with image re-
construction, the total volume of renal cysts in polycystic
kidney mice.
However, since the boxel size in this study was not iso-
metric (0.19 × 0.27 × 0.6 mm), the volume of an individual
cyst might be overestimated because the cyst is smaller
than the z-axis resolution (0.6 mm). Accurate volumetry
of the individual cyst might be accomplished by a smaller
isometric boxel acquisition using the FIESTA method on
the higher magnetic field machine with longer acquisition
time. Therefore, in the current study, we measured the di-
ameter of the cyst in the x-y plane. The reproducibility of
images taken twice within 3 days was very good.
Another feature of the 3D-FIESTA sequence is its de-
pendence on flip angle. Large flip angles produced more
water signal but less tissue contrast. At flip angles of >45◦,
the kidneys became too dark to accurately localize cysts.
Intermediate flip angles (e.g., 45◦) enabled visualization
of both the kidney and the cysts. In the case of polycystic
kidney where most of the renal parenchyma is replaced
with cysts, a greater flip angle might help to measure the
total volume of water in the cysts.
G4 agent–enhanced MRI is good at visualizing the
structure and function of the cortex and outer stripe [1].
We found that the cortex plus outer stripe were thinner in
COX-2 knockout mice than in the littermates. This find-
ing has been reported as one of characteristic effects of
the COX-2 gene deletion to the structure of the kidney
[2].
Rodent models have been used extensively to study
the pathophysiology of renal cystic diseases, especially
polycystic kidney disease. Rodent models have also been
used for preclinical drug discovery studies, with evidence
for inhibition of renal dysfunction and cyst growth using
inhibitors of angiotensin-converting enzyme (ACE), tu-
mor necrosis factor (TNF), and epidermal growth factor
(EGF), and potassium citrate, and soyasaponin [13–17].
Most of these studies relied on plasma markers of renal
function and cyst size at the time of sacrifice. Patients
whose kidneys become enlarged are at higher risk of de-
veloping renal failure, suggesting that monitoring cyst size
might be used to monitor the progression of polycystic
kidney disease [18]. Since MRI can noninvasively mea-
sure cyst size in live mice, it will be much easier to deter-
mine the natural history of each cyst. Furthermore, it may
be possible to screen for drug effects much more rapidly,
since cyst size can be used as a surrogate marker of drug
effect. Finally, MRI will be useful for detecting subtle
structural renal defects in enu-mutagenesis projects that
are currently underway.
CONCLUSION
The micro-MRI method with noncontrast 3D-FIESTA
enabled visualization of renal cysts in living mice to study
changes in individual cysts over time. Therefore, this
micro-MRI method should greatly aid in the non-invasive
investigation of chronic kidney damage in mouse models,
which cause cystic disease of the kidneys.
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